Tim Waterboer Selected Research

Unknown Primary Neoplasms

1/2021	Detection of HPV16/18 E6 Oncoproteins in Head and Neck Squamous Cell Carcinoma Using a Protein Immunochromatographic Assay.
1/2018	Antibodies against human papillomaviruses as diagnostic and prognostic biomarker in patients with neck squamous cell carcinoma from unknown primary tumor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tim Waterboer Research Topics

Disease

70	Neoplasms (Cancer) 03/2022 - 03/2005
42	Infections 01/2022 - 10/2007
22	Papillomavirus Infections 03/2022 - 01/2008
20	Oropharyngeal Neoplasms 11/2022 - 04/2011
14	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 12/2014
13	Uterine Cervical Neoplasms (Cancer of the Cervix) 05/2022 - 10/2005
13	Stomach Neoplasms (Stomach Cancer) 10/2021 - 11/2015
13	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 10/2007
10	Squamous Cell Carcinoma of Head and Neck 10/2021 - 04/2011
7	Head and Neck Neoplasms (Head and Neck Cancer) 01/2022 - 10/2012
6	Multiple Sclerosis 01/2022 - 02/2016
6	Basal Cell Carcinoma (Rodent Ulcer) 01/2021 - 01/2008
5	Skin Neoplasms (Skin Cancer) 03/2022 - 11/2008
5	Anus Neoplasms (Anal Cancer) 01/2022 - 03/2015
5	Carcinogenesis 08/2019 - 02/2010
4	Lung Neoplasms (Lung Cancer) 01/2022 - 07/2014
4	Nasopharyngeal Carcinoma 01/2022 - 11/2019
4	Epstein-Barr Virus Infections 12/2021 - 01/2019
4	Carcinoma (Carcinomatosis) 01/2021 - 04/2011
3	Coinfection 03/2022 - 12/2020
3	Infectious Mononucleosis (Glandular Fever) 01/2021 - 01/2019
3	Virus Diseases (Viral Diseases) 01/2020 - 02/2011
3	Persistent Infection 01/2019 - 01/2016
2	COVID-19 01/2022 - 01/2021
2	Uterine Cervical Dysplasia 01/2022 - 01/2022
2	Papilloma (Papillomatosis) 01/2022 - 02/2011
2	Hypertension (High Blood Pressure) 01/2022 - 01/2019
2	Glioma (Gliomas) 01/2022 - 01/2021
2	Stomach Diseases 01/2021 - 10/2017
2	Neoplasm Metastasis (Metastasis) 01/2021 - 05/2013
2	Unknown Primary Neoplasms 01/2021 - 01/2018
2	Obesity 01/2021 - 01/2021
2	Condylomata Acuminata (Genital Wart) 01/2021 - 10/2009
2	Squamous Intraepithelial Lesions 11/2020 - 01/2010
2	Metrorrhagia (Spotting) 11/2020 - 02/2019
2	Acquired Immunodeficiency Syndrome (AIDS) 01/2020 - 01/2019
2	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 01/2019
2	Liver Neoplasms (Liver Cancer) 01/2020 - 01/2019
2	Hepatitis B 01/2020 - 01/2018
2	Testicular Neoplasms (Testicular Cancer) 12/2019 - 12/2019
2	Melanoma (Melanoma, Malignant) 01/2018 - 01/2015
2	Herpes Simplex 11/2016 - 09/2012
2	Polyomavirus Infections 10/2016 - 02/2013
1	HIV Infections (HIV Infection) 03/2022
1	Hepatitis 01/2022
1	Reinfection 01/2022
1	Insulin Resistance 01/2022
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 10/2021

Drug/Important Bio-Agent (IBA)

91	AntibodiesIBA 05/2022 - 10/2005
40	Biomarkers (Surrogate Marker)IBA 03/2022 - 11/2008
39	Proteins (Proteins, Gene)FDA Link 05/2022 - 12/2009
39	DNA (Deoxyribonucleic Acid)IBA 03/2022 - 03/2005
30	AntigensIBA 01/2022 - 01/2015
12	ORALIT (ORS)IBA 01/2022 - 08/2012
10	Oncogene Proteins (Oncogene Protein)IBA 11/2022 - 10/2005
10	VaccinesIBA 10/2021 - 06/2007
8	Immunoglobulin G (IgG)IBA 01/2022 - 11/2016
6	ProteomeIBA 01/2021 - 01/2018
6	Capsid Proteins (Capsid Protein)IBA 01/2021 - 06/2007
5	Immunoglobulin A (IgA)IBA 01/2022 - 01/2019
5	RNA (Ribonucleic Acid)IBA 11/2017 - 07/2014
4	EBV-encoded nuclear antigen 1IBA 12/2021 - 01/2020
4	Cytotoxins (Cytolysins)IBA 12/2021 - 06/2020
4	Biological ProductsIBA 10/2021 - 01/2008
4	Papillomavirus Vaccines (HPV Vaccines)IBA 01/2021 - 01/2016
4	Messenger RNA (mRNA)IBA 01/2018 - 10/2012
3	Glutathione Transferase (Glutathione S-Transferase)IBA 05/2022 - 02/2011
3	Contraceptive Agents (Contraceptives)IBA 01/2022 - 01/2016
3	Virulence Factors (Pathogenicity Factors)IBA 01/2021 - 06/2020
3	Viral DNAIBA 01/2021 - 07/2015
3	AutoantibodiesIBA 01/2018 - 01/2016
2	ImmunosorbentsIBA 05/2022 - 02/2010
2	EnzymesIBA 05/2022 - 02/2010
2	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 01/2021
2	Combined VaccinesIBA 10/2021 - 01/2016
2	HLA-DRB1 Chains (HLA DRB1)IBA 01/2021 - 01/2021
2	Viral AntigensIBA 01/2020 - 10/2018
2	AnoctaminsIBA 01/2019 - 02/2016
2	FlagellinIBA 01/2019 - 01/2019
2	Urea (Carbamide)FDA LinkGeneric 10/2017 - 12/2009
2	Nucleic AcidsIBA 10/2016 - 01/2010
2	Cyclin-Dependent Kinase Inhibitor p16IBA 07/2016 - 10/2012
2	CatalaseIBA 04/2016 - 12/2009
2	Rituximab (Mabthera)FDA Link 01/2016 - 10/2015
2	Tumor Viral Antigens (Large T Antigen)IBA 01/2015 - 06/2007
1	Epstein-Barr virus early antigenIBA 01/2022
1	A-Form DNA (A-DNA)IBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	cytomegalovirus-specific hyperimmune globulinIBA 01/2022
1	Antinuclear AntibodiesIBA 01/2022
1	Circulating Tumor DNAIBA 01/2022
1	LipidsIBA 01/2022
1	Vitamin D FDA LinkGeneric 12/2021
1	Estrogen Receptor alphaIBA 10/2021
1	Eflornithine (Ornidyl)FDA Link 10/2021
1	Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA 10/2021

Therapy/Procedure

3	Therapeutics 01/2020 - 06/2010
2	Aftercare (After-Treatment) 01/2020 - 01/2017
2	Organ Transplantation 01/2015 - 02/2013
1	Chemoprevention 10/2021